BioQuest Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioQuest Corp. generated cash of -$62,689, which is less than the previous year. Cash used in financing activities reached the amount of $35,000 last year. Net change in cash is therefore -$27,689.
Cash Flow
| 2013 | -7.62K | 0 | 14.66K |
|---|---|---|---|
| 2014 | -600.34K | 0 | 1.13M |
| 2019 | 2 | 0 | 0 |
| 2020 | -124.83K | 0 | 125K |
| 2021 | -193.20K | 0 | 193.3K |
| 2022 | -116.72K | 0 | 150K |
| 2023 | -53.50K | 0 | 20K |
| 2024 | -62.68K | 0 | 35K |
BQST Cash Flow Statement (2013 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31 | 33.54K | 260 | 166 | 0 | 0 | 7.97K | 946 |
Operating activities | ||||||||
Net income | -123.32K | -140.66K | -821.02K | -2.32M | -359.02K | -2.17K | -616.18K | -8.27K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 24.09K | 0 | 0 | 0 | 648 | 648 |
Stock-based compensation expense | 50K | 0 | 206.7K | 530K | 117.27K | 0 | 0 | 0 |
| Deferred income tax benefit | 50K | 0 | 206.7K | 530K | 117.27K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 6.67K | 156.58K | 36.51K | 0 | 14.7K | 0 |
Cash generated by operating activities | -62.68K | -53.50K | -116.72K | -193.20K | -124.83K | 2 | -600.34K | -7.62K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 65K | 135K | 55K | 0 | 1.48M | 14.56K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 85K | -58.3K | -40K | 0 | 0 | 0 |
Cash used in financing activities | 35K | 20K | 150K | 193.3K | 125K | 0 | 1.13M | 14.66K |
Net Change In Cash | -27.68K | -33.50K | 33.28K | 94 | 166 | 2 | 535.87K | 7.03K |
Cash at end of period | -27.65K | 31 | 33.54K | 260 | 166 | 2 | 543.85K | 7.97K |
| Data source | Data source | Data source |